Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
Innate Pharma (IPHA) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Innate Pharma
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Innate Pharma - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | -19.91% |
| 2021-12-31 | $0.13 B | -27.24% |
| 2020-12-31 | $0.18 B | -23.93% |
| 2019-12-31 | $0.24 B | 27.93% |
| 2018-12-31 | $0.19 B | 37.5% |
| 2017-12-31 | $0.13 B | -33.02% |
| 2016-12-31 | $0.20 B | -19.32% |
| 2015-12-31 | $0.25 B | 206.32% |
| 2014-12-31 | $84.2 M | 47.47% |
| 2013-12-31 | $57.1 M | 32.36% |
| 2012-12-31 | $43.14 M | -28.57% |
| 2011-12-31 | $60.4 M | 31.32% |
| 2010-12-31 | $45.99 M | -34.74% |
| 2009-12-31 | $70.48 M | 49.02% |
| 2008-12-31 | $47.29 M | -36.21% |
| 2007-12-31 | $74.14 M | -6.24% |
| 2006-12-31 | $79.07 M | 264.85% |
| 2005-12-31 | $21.67 M |